Skip to main content
Isomer
  1. Home
  2. Automated
  3. List of product information
  4. CLOXACAP 250 CAPSULE 250 MG [SIN05036P]

CLOXACAP 250 CAPSULE 250 MG [SIN05036P]

Active ingredients: CLOXACAP 250 CAPSULE 250 MG

Last updated 26 October 2025

Product Info

CLOXACAP 250 CAPSULE 250 MG

[SIN05036P]

Product information

Active Ingredient and Strength

CLOXACILLIN SODIUM EQV CLOXACILLIN - 250 MG

Dosage Form

CAPSULE

Manufacturer and Country

HOVID BHD - MALAYSIA

Registration Number

SIN05036P

Licence Holder

GOLDPLUS UNIVERSAL PTE LTD

Forensic Classification

PRESCRIPTION ONLY MEDICINES

Anatomical Therapeutic Chemical (ATC) code

J01CF02

INDICATIONS
For treatment of:

  • Infections caused by penicillinase-producing staphylococci

  • Respiratory tract infections

  • Skin and soft-tissue infections

  • Disseminated infections caused by pneumococci, group A beta-hemolytic streptococci and penicillin G-resistant and penicillin G-sensitive staphylococci

DOSAGE AND ADMINISTRATION
Cloxacillin should not be used orally for the initial treatment of severe life-threatening infections, but may be used as a follow-up therapy after parenteral penicillinase-resistant penicillin therapy.

Adult dose
Oral, 250 to 500 mg every six hours; or as directed.

Paediatric dose
Infants and children up to 20 kg of body weight:
Oral 12.5 to 25 mg per kg of body weight every six hours; or as directed.

Children 20 kg of body weight and over - See adult dose.

Note: The information given here is limited. For further information, consult your doctor or pharmacist.

CONTRAINDICATIONS
Avoid in patients known to be hypersensitive to penicillins.